Trademark: 88673382
Word
TRANSFORM ONCOLOGY CARE
Status Date
Tuesday, October 12, 2021
Registration Number
6521433
Registration Date
Tuesday, October 12, 2021
Filing Date
Wednesday, October 30, 2019
Published for Opposition
Tuesday, June 9, 2020
35 Specialty pharmaceutical distributorship services, namely, distributorships featuring pharmaceuticals; pharmaceutical cost management for the health care benefit plans of others; pharmaceutical utilization review services; prescription drug formulary cost and business management services, namely, clinical and cost-effectiveness reviews following evidence-based medicine and incorporation of value-based criteria into formulary designs; business administration of pharmacy reimbursement programs and services; Medical referrals; Managed care services, namely, electronic processing of health care and pharmaceutical information; Business management in the field of clinical trials, namely, providing information management services
36 Insurance claims administration for medical claims and pharmaceuticals, processing of insurance claims and payment data; pharmacy benefit management services; insurance claims processing of pharmaceutical benefits; financial administration of pharmacy reimbursement programs and services
44 Providing health services, namely, personal health assessments and screenings; disease care management services; Medical services in the field of oncology, namely, prior authorization services, therapy and diagnostic services, and treatment support services; Nursing services; Therapeutic pharmaceutical services, namely, dispensing of pharmaceuticals and counseling on medications, incorporating disease monitoring services and clinical reviews; pharmaceutical advice; disease management programs; Medical services, namely, providing in-home and ambulatory infusion pharmacy services, and providing oncology services
45 Specialty care management services, namely, providing case management services in the nature of coordinating medical care for persons with medical conditions requiring specialized care
Oct 12, 2021
Registered-Principal Register
Sep 7, 2021
Notice Of Acceptance Of Statement Of Use E-Mailed
Sep 4, 2021
Allowed Principal Register - Sou Accepted
Aug 26, 2021
Statement Of Use Processing Complete
Aug 20, 2021
Use Amendment Filed
Aug 24, 2021
Case Assigned To Intent To Use Paralegal
Aug 20, 2021
Teas Statement Of Use Received
Jul 24, 2021
Notice Of Approval Of Extension Request E-Mailed
Jul 22, 2021
Extension 2 Granted
Jul 22, 2021
Extension 2 Filed
Jul 22, 2021
Teas Extension Received
Jan 22, 2021
Notice Of Approval Of Extension Request E-Mailed
Jan 20, 2021
Extension 1 Granted
Jan 20, 2021
Extension 1 Filed
Jan 20, 2021
Teas Extension Received
Aug 4, 2020
Noa E-Mailed - Sou Required From Applicant
Jun 9, 2020
Official Gazette Publication Confirmation E-Mailed
Jun 9, 2020
Published For Opposition
May 20, 2020
Notification Of Notice Of Publication E-Mailed
Apr 29, 2020
Approved For Pub - Principal Register
Apr 28, 2020
Teas/Email Correspondence Entered
Apr 27, 2020
Correspondence Received In Law Office
Apr 27, 2020
Teas Response To Office Action Received
Nov 29, 2019
Notification Of Non-Final Action E-Mailed
Nov 29, 2019
Non-Final Action E-Mailed
Nov 29, 2019
Non-Final Action Written
Nov 21, 2019
Assigned To Examiner
Nov 8, 2019
Teas Amendment Entered Before Attorney Assigned
Nov 8, 2019
Teas Voluntary Amendment Received
Nov 2, 2019
New Application Office Supplied Data Entered In Tram
Nov 2, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
